MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2022 International Congress

    IncobotulinumtoxinA to treat sialorrhea in Parkinson’s disease: a real-life study

    B. Bergmans, N. Winter, V. Schotte, N. Sys, E. van Massenhove, H. Couckuyt, M. van Zandijcke (Bruges & Ghent, Belgium)

    Objective: We evaluate the long-term efficacy and safety of incobotulinumtoxinA injections in advanced Parkinson’s disease (PD) patients suffering from sialorrhea (10 injection cycles (IC) into…
  • 2022 International Congress

    Safety and tolerability of Nilotinib in patients with Huntington’s disease

    K. Anderson (Washington, USA)

    Objective: To investigate the safety and tolerability of nilotinib, an FDA-approved drug for leukemia, in individuals with Huntington’s disease (HD). Background: Previous clinical studies in…
  • 2022 International Congress

    Comorbidities in Huntington’s disease: An Enroll-HD analysis

    J. Mills, J. Long, J. Vaidya, C. Sampaio, S. Sathe (Iowa City, USA)

    Objective: Determine the frequency of comorbidities in people with Huntington’s disease (PwHD) in comparison to non-carrier controls in the Enroll-HD cohort. Background: Despite some publications…
  • 2022 International Congress

    Diagnostic Utility of I123-FP-CIT Single Photon Emission Computed Tomography for Patients with Clinically Uncertain Parkinsonian Syndrome

    R. Falconer, T. Hunter, E. Szabo, C. Brand (Alexandria, USA)

    Objective: This study investigated the impact of I123-FP-CIT single photon emission computed tomography (SPECT) for the diagnosis of patients with clinically uncertain parkinsonian syndrome (CUPS)…
  • 2022 International Congress

    Non-dopaminergic system is related with motor reserve in Parkinson’s disease

    J. Youn, JH. Won, M. Kim, SH. Moon, M. Kim, JH. Ahn, YE. Huh, H. Park, JW. Cho (Seoul, Republic of Korea)

    Objective: To find related brain structures with the motor reserve in Parkinson's disease (PD). Background: There is a discrepancy between the severity of parkinsonism and dopaminergic…
  • 2022 International Congress

    Amantadine Is Effective Long-term in Parkinson’s Disease

    S. Park, BS. Jeon (Daejeon, Republic of Korea)

    Objective: This study aimed to investigate the long-term effectiveness of amantadine in patients with PD. Background: Amantadine has been used in the symptomatic treatment of…
  • 2022 International Congress

    Movement Disorders Associated With Vitamin B12 Deficiency: A Case Series

    R. Zouari, L. Hlioui, F. Nabli, MZ. Saeid, C. Jeridi, S. Blel, S. Ben Sassi (tunis, Tunisia)

    Objective: we present a case series of movement disorders (MD) due to vitamin B12 deficiency (VB12D) and compare them with the cases reported in the…
  • 2022 International Congress

    Effects of Subthalamic Nucleus Deep Brain Stimulation on pain in Parkinson disease: Real-life observational prospective study

    I. Carvalho, D. Damas, I. Cunha, S. Caldeira, P. Monteiro, R. Pereira, F. Moreira (Coimbra, Portugal)

    Objective: To evaluate the effect of subthalamic nucleus deep brain stimulation (STN-DBS) on the different characteristics of pain in patients with Parkinson disease (PD). Background:…
  • 2022 International Congress

    Post anoxic chorea: a rare complication after anoxic brain injury

    C. Wantaneeyawong, K. Thiankhaw (Chiang Mai, Thailand)

    Objective: To report a case of post anoxic chorea which is considered as a rare complication of post cardiac arrest. Background: Neurologic complication is a…
  • 2022 International Congress

    Unravelling Hidden Mutations Behind the Heterozygos SYNE1 Genotype

    Y. Salamatova, L. Terpak, E. Giatour, N. Shneyder (jacksonville, USA)

    Objective: To present case series of four patients of heterozygous for SYNE1 mutation with phenotype consistent with cerebellar ataxia. Background: Recessive cerebellar ataxias are defined as disorders with autosomal recessive…
  • « Previous Page
  • 1
  • …
  • 635
  • 636
  • 637
  • 638
  • 639
  • …
  • 1734
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley